Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients

American Journal of Medical Genetics

Volumn 103, Issue 2, 2001, Pages 115-120

  Werneck, Lineu Cesar ^a   Scola, Rosana Herminia ^a   Maegawa, Gustavo Henrique Boff ^a   Werneck, Maurício Cesar Moura ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Becker muscular dystrophy; DNA deletion; Duchenne muscular dystrophy; Dystrophin; Immunohistochemistry; Muscle biopsy; Polymerase chain reaction

Indexed keywords

DYSTROPHIN;

ADOLESCENT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ETHNIC DIFFERENCE; EXON; FEMALE; GENE DELETION; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CELL; MUSCLE TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOLEMMA;

BRAZIL; DNA; DYSTROPHIN; FEMALE; GENE DELETION; GENE FREQUENCY; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCULAR DYSTROPHY, DUCHENNE; POLYMERASE CHAIN REACTION;

EID: 0035479196     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1508     Document Type: Article

References (53)

1. A convenient multiplex PCR system for the detection of dystrophin deletions: A comparative analysis with cDNA hybridization shows mistypings by both methods
2. Impact of carrier status determination for Duchenne/Becker muscular dystrophy by computer-assisted laser densitometry
3. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population
4. Accurate and rapid detection of heterozygous carriers of a deletion by combined polymerase chain reaction and high-performance liquid chromatography
5. Germline mosaicism and Duchenne muscular dystrophy mutations
6. Are there ethnic differences in deletions in the dystrophin gene?
7. Molecular and clinical correlation of deletion leading to Duchenne and Becker muscular dystrophies
8. Detection of 98% of DMD/BMD gene deletions by polymerize chain reaction
9. Cytogenetic heterogeneity of translocations associated with Duchenne muscular dystrophy
10. Clinical trial in Duchenne dystrophy: I. The design of the protocol
11. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy
12. Premature chain termination mutation causing Duchenne muscular dystrophy
13. Pattern of deletions of the dystrophin gene in Mexican Duchenne/Becker muscular dystrophy patients: The use of the new designed primers for the analysis of the major deletion "hot-spot" region
14. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications
15. Detection of carriers of benign X-linked muscular dystrophy
16. Dystrophinopathies
17. Screening for deletions in Duchenne and Becker muscular dystrophy patients using the genomic probe P20 and the cDNA XJ10 (1-2b), 7b-8 and 44-1 (8) probes
18. Rapid direct diagnosis of deletions carriers of Duchenne and Becker muscular dystrophies
19. Optimization of extraction from formalin-fixed tissue and its clinical application in Duchenne muscular dystrophy
20. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncated test
21. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene
22. Becker dystrophy
23. Dystrophin: The protein product of the Duchenne muscular dystrophy locus
24. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy
25. Genetic counseling of isolated carriers of Duchenne muscular dystrophy
26. Duplicational mutation at the Duchenne muscular dystrophy locus: Its frequency, distribution, origin and phenotype-genotype correlation
27. Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction
28. Point mutations and polymorphism in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR
29. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
30. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
31. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion
32. Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene
33. Gene deletions in X-linked muscular dystrophy
34. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies
35. Isolation of candidate cDNA for portions of the Duchenne muscular dystrophy gene
36. The manifesting carrier in Duchenne muscular dystrophy
37. Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a and Cf115
38. Heteroduplex analysis of the dystrophin gene: Application to point mutation and carrier detection
39. Direct carrier detection by in situ hybridization with cosmid clones of the Duchenne/Becker muscular dystrophy locus
40. Point mutations in the dystrophin gene
41. Splicing mutation in DMD/BMD detected by RT-PCR/PTT: Detection of a 19AA insertion in the cysteine rich domain of the dystrophin compatible with BMD
42. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels
43. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients
44. Proportion and pattern of dystrophin gene deletions in north Indian Duchenne and Becker muscular dystrophy patients
45. The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced
46. Mutation analysis of muscle and brain specific promoter regions of dystrophin in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE)
47. O valor da biápsia muscular em neurologia. Análise de 290 a fresco e pela histoquímica
48. Differenciaçāo precoce entre distrofia muscular de Duchenne e de Becker. Estudo clínico, laboratorial, electrofisiológico, histoquímico e immunocitoquímico de 138 casos
49. Distrofina na differenciaçāo das distrofias de Duchenne e Becker: Estudo Imuno-histoquímico comparado com o estadio clínico, enzimas séricas e biópsia muscular
50. Muscular dystrophy: Diseases of the dystrophin-glycoprotein complex
51. Accurate diagnosis of carriers of deletions and duplication in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis